With the arrival of this shipment, Argentina will exceed the 36 million doses of vaccines against him coronavirus received since the beginning of the immunization plan.
As we celebrate the delivery of vaccines by the United States, Alberto Fernandez, noted that “the pandemic is a warning and, at the same time, an opportunity to move towards more equitable, more inclusive and just societies”, and stressed that “this donation from the United States Government is a very important contribution that marks a path cooperation “, as officially reported.
In addition, it was specified that This solidarity delivery of vaccines is the most numerous to a single country in the region by the United States.
This arrival was the consequence of the signing by the Executive Power, on July 3, of a DNU that enabled an agreement with the laboratory Moderna Inc. for supplying 20 million doses of its Covid-19 vaccine or equivalent doses of the vaccine as a booster.
The coronavirus vaccine developed by the American biotechnology company Moderna was designed through the messenger RNA technology for the immune system to learn to repel part of the virus protein, and demonstrated a high rate of effectiveness among adolescents 12 to 17 years of age.
Meanwhile, a new Aerolineas Argentinas flight from China is scheduled for this afternoon with a shipment of 768,000 Sinopharm vaccines against the coronavirus.
This is the sixth of the ten trips planned for July to complete eight million doses, within the framework of the contract signed with the China National Pharmaceutical Group Corp for a total of 24 million vaccines until September.
Yesterday, the fifth of those flights arrived, from Beijing, with 768,000 doses of Sinopharm. Adding up today’s Chinese doses and the Moderna vaccines that will arrive tomorrow, Argentina will reach a total of 36,291,730 vaccines since the beginning of the population inoculation plan.
So far, a total of 32,023,730 doses have arrived, of which 11,868,830 correspond to Sputnik V, (9,375,670 for component 1 and 2,493,160 for component 2); 9,840,000 to Sinopharm; 580,000 to AstraZeneca-Covishield, 1,944,000 to AstraZeneca through the WHO Covax mechanism, and 7,790,900 to those of AstraZeneca and Oxford, the active ingredient of which was produced in Argentina.
